NCT06619990Phase 1, phase 2Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Study sponsor: Xencor, Inc. · XNCR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12Estimated
Enrollment · participants270Estimated
Source updated2026-10-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.